Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways

Glycolipid metabolic disorders (GLMDs) are various metabolic disorders resulting from dysregulation in glycolipid levels, consequently leading to an increased risk of obesity, diabetes, liver dysfunction, neuromuscular complications, and cardiorenal vascular diseases (CRVDs). In patients with GLMDs, excess caloric intake and a lack of physical activity may contribute to oxidative stress (OxS) and systemic inflammation. This study aimed to review the connection between GLMD, OxS, metainflammation, and the onset of CRVD. GLMD is due to various metabolic disorders causing dysfunction in the synthesis, breakdown, and absorption of glucose and lipids in the body, resulting in excessive ectopic accumulation of these molecules. This is mainly due to neuroendocrine dysregulation, insulin resistance, OxS, and metainflammation. In GLMD, many inflammatory markers and defense cells play a vital role in related tissues and organs, such as blood vessels, pancreatic islets, the liver, muscle, the kidneys, and adipocytes, promoting inflammatory lesions that affect various interconnected organs through their signaling pathways. Advanced glycation end products, ATP-binding cassette transporter 1, Glucagon-like peptide-1, Toll-like receptor-4, and sphingosine-1-phosphate (S1P) play a crucial role in GLMD since they are related to glucolipid metabolism. The consequences of this is system organ damage and increased morbidity and mortality.

[1]  B. Burla,et al.  Plasma and platelet lipidome changes in Fabry disease. , 2024, Clinica chimica acta; international journal of clinical chemistry.

[2]  Sulaiman K. Marafie,et al.  mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process , 2024, International journal of molecular sciences.

[3]  Jialin Fan,et al.  Nuclear mTOR Signaling Orchestrates Transcriptional Programs Underlying Cellular Growth and Metabolism , 2024, Cells.

[4]  E. Dósa,et al.  Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease. , 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  Nair Anaga,et al.  (+)-Catechin mitigates impairment in insulin secretion and beta cell damage in methylglyoxal-induced pancreatic beta cells. , 2024, Molecular biology reports.

[6]  Qiang Li,et al.  Insulin resistance, combined with health-related lifestyles, psychological traits and adverse cardiometabolic profiles, is associated with cardiovascular diseases: findings from the BHMC study. , 2024, Food & function.

[7]  H. Ou,et al.  Naringenin Inhibits Acid Sphingomyelinase-Mediated Membrane Raft Clustering to Reduce NADPH Oxidase Activation and Vascular Inflammation. , 2024, Journal of agricultural and food chemistry.

[8]  Sarika Gupta,et al.  Diabetes: a review of its pathophysiology, and advanced methods of mitigation , 2024, Current medical research and opinion.

[9]  Qing Xia,et al.  Dimethyl phthalate induced cardiovascular developmental toxicity in zebrafish embryos by regulating MAPK and calcium signaling pathways. , 2024, The Science of the total environment.

[10]  En Ma,et al.  Resveratrol protects against myocardial ischemic injury in obese mice via activating SIRT3/FOXO3a signaling pathway and restoring redox homeostasis. , 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  A. Chabowski,et al.  Adipose tissue place of origin and obesity influence sphingolipid signaling pathway in the adipocytes differentiated from ADMSCs isolated from morbidly obese women. , 2024, Biochemical pharmacology.

[12]  R. Touyz,et al.  Mechanisms of Vascular Inflammation and Potential Therapeutic Targets: A Position Paper From the ESH Working Group on Small Arteries , 2024, Hypertension.

[13]  M. Johansson,et al.  GLP-1R signaling modulates colonic energy metabolism, goblet cell number and survival in the absence of gut microbiota , 2024, Molecular metabolism.

[14]  A. Degasperi,et al.  Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner , 2024, Nature communications.

[15]  Y. Qiao,et al.  Mitochondria-associated endoplasmic reticulum membrane (MAM): a dark horse for diabetic cardiomyopathy treatment , 2024, Cell death discovery.

[16]  Mirinthorn Jutanom,et al.  Oxidized-LDL Induces Metabolic Dysfunction in Retinal Pigment Epithelial Cells. , 2024, Biological & pharmaceutical bulletin.

[17]  A. Palotie,et al.  Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity. , 2024, JAMA cardiology.

[18]  N. Kongruttanachok,et al.  GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome , 2024, BMC cardiovascular disorders.

[19]  Lipidomics reveals new lipid-based lung adenocarcinoma early diagnosis model , 2024, EMBO molecular medicine.

[20]  Julie K. Freed,et al.  Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis , 2024, Circulation research.

[21]  Le-Kun Gui,et al.  Krüpple-like factors in cardiomyopathy: emerging player and therapeutic opportunities , 2024, Frontiers in cardiovascular medicine.

[22]  Y. Son,et al.  The role of 27-hydroxycholesterol in meta-inflammation , 2024, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[23]  H. Teoh,et al.  GLP-1 receptor agonists and vascular protection. , 2024, American journal of physiology. Heart and circulatory physiology.

[24]  Cong-Cong Ju,et al.  Epigenetic modification: A novel insight into diabetic wound healing , 2024, Heliyon.

[25]  M. Alraies,et al.  Comparative Efficacy and Safety of Mitral Valve Repair Versus Mitral Valve Replacement in Improving Clinical Outcomes in Patients with Rhematic Heart Disease: A High-Value Care Systematic Review and Meta-Analysis. , 2024, Current problems in cardiology.

[26]  Suman Dalal,et al.  Vagus nerve stimulation alleviates cardiac dysfunction and inflammatory markers during heart failure in rats , 2024, Autonomic Neuroscience.

[27]  B. Glancy,et al.  Reorganization of mitochondria–organelle interactions during postnatal development in skeletal muscle , 2024, The Journal of physiology.

[28]  O. Ogurkova,et al.  [Biomarkers of Inflammation in Predicting the Outcomes of Heart Failure of Ischemic Etiology: the Results of Factor Analysis]. , 2024, Kardiologiia.

[29]  Junming Ye,et al.  How do sphingosine-1-phosphate affect immune cells to resolve inflammation? , 2024, Frontiers in immunology.

[30]  C. Chu,et al.  The interactions and biological pathways among metabolomics products of patients with coronary heart disease. , 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[31]  B. Bagheri,et al.  Atherosclerosis and Toll-Like Receptor4 (TLR4), Lectin-Like Oxidized Low-Density Lipoprotein-1 (LOX-1), and Proprotein Convertase Subtilisin/Kexin Type9 (PCSK9) , 2024, Mediators of inflammation.

[32]  G. Gallo,et al.  Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities , 2024, International journal of molecular sciences.

[33]  C. Erridge,et al.  Toll-like receptor stimulants in processed meats promote lipid accumulation in macrophages and atherosclerosis in Apoe-/- mice. , 2024, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[34]  Bo Huang,et al.  Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG , 2024, Science.

[35]  A. Lautenbach,et al.  Obesity management: sex-specific considerations , 2024, Archives of gynecology and obstetrics.

[36]  F. Garcia,et al.  Dithiothreitol reduces oxidative stress and necrosis caused by ultraviolet A radiation in L929 fibroblasts. , 2024, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[37]  Chao Liu,et al.  A pan-PPAR agonist E17241 ameliorates hyperglycemia and diabetic dyslipidemia in KKAy mice via up-regulating ABCA1 in islet, liver, and white adipose tissue. , 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  Scott A. Summers,et al.  Ceramides are Fuel Gauges on the Drive to Cardiometabolic Disease. , 2024, Physiological reviews.

[39]  C. Macchi,et al.  Exploring the role of epicardial adipose-tissue-derived extracellular vesicles in cardiovascular diseases , 2024, iScience.

[40]  Hui Yao,et al.  Downregulation of VEGFA accelerates AGEs-mediated nucleus pulposus degeneration through inhibiting protective mitophagy in high glucose environments. , 2024, International journal of biological macromolecules.

[41]  Akiko Sakai-Sakasai,et al.  Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite , 2024, Biomolecules.

[42]  Alexander V. Panov The Structure of the Cardiac Mitochondria Respirasome Is Adapted for the β-Oxidation of Fatty Acids , 2024, International journal of molecular sciences.

[43]  Jianqing Lin,et al.  Sphingolipid metabolism controls mammalian heart regeneration. , 2024, Cell metabolism.

[44]  V. Olkkonen,et al.  Adipocyte-endothelial cell interplay in adipose tissue physiology. , 2024, Biochemical pharmacology.

[45]  Huijuan Luo,et al.  MiR-375 Inhibitor Alleviates Inflammation and Oxidative Stress by Upregulating the GPR39 Expression in Atherosclerosis. , 2024, International heart journal.

[46]  Chong-Zhi Wang,et al.  Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis , 2024, BMJ.

[47]  Yipu Huang,et al.  Fructose aggravates copper-deficiency-induced cardiac remodeling by inhibiting SERCA2a. , 2024, The Journal of pharmacy and pharmacology.

[48]  Zichong Song,et al.  Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy , 2024, International journal of medical sciences.

[49]  I. Gianopoulos,et al.  Macrophage profiling in atherosclerosis: understanding the unstable plaque. , 2024, Basic research in cardiology.

[50]  Rui Li,et al.  ACE2 Regulates Glycolipid Metabolism in Multiple Tissues. , 2024, Frontiers in bioscience.

[51]  Qin Zhang,et al.  Gut microbiota dysbiosis and decreased levels of acetic and propionic acid participate in glucocorticoid-induced glycolipid metabolism disorder , 2024, mBio.

[52]  Yasushi Mukai Inflammation and atrial fibrillation , 2024, Journal of arrhythmia.

[53]  E. Brady,et al.  Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes , 2024, BMC cardiovascular disorders.

[54]  Qi Guo,et al.  Myeloid-derived grancalcin instigates obesity-induced insulin resistance and metabolic inflammation in male mice , 2024, Nature communications.

[55]  I. Mori,et al.  Sphingosine 1-Phosphate Regulates Obesity and Glucose Homeostasis , 2024, International journal of molecular sciences.

[56]  Juan S Peña,et al.  Neurovascular Relationships in AGEs-Based Models of Proliferative Diabetic Retinopathy , 2024, Bioengineering.

[57]  Ali Attiq,et al.  Hegemony of inflammation in atherosclerosis and coronary artery disease. , 2024, European journal of pharmacology.

[58]  Sharif hasan Siddiqui,et al.  Acute Intake of Fructose Increases Arterial Pressure in Humans: A Meta-Analysis and Systematic Review , 2024, Nutrients.

[59]  C. Indolfi,et al.  Pathophysiology of Atrial Fibrillation and Approach to Therapy in Subjects Less than 60 Years Old , 2024, International journal of molecular sciences.

[60]  Jiawei Zheng,et al.  Inhibition of Hyperglycemia and Hyperlipidemia by Blocking Toll-like Receptor 4: Comparison of Wild-Type and Toll-like Receptor 4 Gene Knockout Mice on Obesity and Diabetes Modeling , 2024, Biology.

[61]  S. Rovira-Llopis,et al.  Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress. , 2024, Free radical biology & medicine.

[62]  Brian C. Case,et al.  Targeting inflammation in atherosclerosis: overview, strategy and directions. , 2024, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[63]  Yujun Jiang,et al.  Lactobacillus paracasei JY062 Alleviates Glucolipid Metabolism Disorders via the Adipoinsular Axis and Gut Microbiota , 2024, Nutrients.

[64]  J. Terrand,et al.  Cholesterol Trafficking, Lysosomal Function and Atherosclerosis. , 2023, American journal of physiology. Cell physiology.

[65]  Yun Ling,et al.  Dysregulation of Ceramide Metabolism Is Linked to Iron Deposition and Activation of Related Pathways in the Aorta of Atherosclerotic Miniature Pigs , 2023, Antioxidants.

[66]  Aijuan Qu,et al.  Diabetes Mellitus to Accelerated Atherosclerosis: Shared Cellular and Molecular Mechanisms in Glucose and Lipid Metabolism. , 2023, Journal of cardiovascular translational research.

[67]  P. Nagareddy,et al.  Impact of age and sex on myelopoiesis and inflammation during myocardial infarction. , 2023, Journal of molecular and cellular cardiology.

[68]  F. Priego-Capote,et al.  Comprehensive profiling of ceramides in human serum by liquid chromatography coupled to tandem mass spectrometry combining data independent/dependent acquisition modes. , 2023, Analytica chimica acta.

[69]  R. Lataro,et al.  Inflammation of some visceral sensory systems and autonomic dysfunction in cardiovascular disease , 2023, Autonomic Neuroscience.

[70]  Mohammad S. Mubarak,et al.  Reactive oxygen species in biological systems: Pathways, associated diseases, and potential inhibitors—A review , 2023, Food science & nutrition.

[71]  Xuan Zhao,et al.  Associations Between Serum TNF-α, IL-6, hs-CRP and GLMD in Obese Children and Adolescents: A Cross-Sectional Study , 2023, Diabetes, metabolic syndrome and obesity : targets and therapy.

[72]  Julie K. Freed,et al.  Necessary Role of Ceramides in the Human Microvascular Endothelium During Health and Disease , 2023, Circulation research.

[73]  D. Kapogiannis,et al.  Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model , 2023, Translational Neurodegeneration.

[74]  B. Bouillet,et al.  Screening and management of metabolic complications of mTOR inhibitors in real-life settings. , 2023, Annales d'endocrinologie.

[75]  M. Sarzynski,et al.  Effects of exercise training on ANGPTL3/8 and ANGPTL4/8 and their associations with cardiometabolic traits , 2023, Journal of lipid research.

[76]  Yatao Huang,et al.  Stereoselective cardiotoxic effects of metconazole on zebrafish (Danio rerio) based on AGE-RAGE signalling pathway. , 2023, The Science of the total environment.

[77]  Zheng Shen,et al.  Nutrient-sensing growth hormone secretagogue receptor in macrophage programming and meta-inflammation , 2023, Molecular metabolism.

[78]  Deshi Dong,et al.  Vanin1 (VNN1) in chronic diseases: Future directions for targeted therapy. , 2023, European journal of pharmacology.

[79]  Ziyan Zhao,et al.  Ganglioside GM3 Protects Against Abdominal Aortic Aneurysm by Suppressing Ferroptosis , 2023, Circulation.

[80]  María del Pilar Ramos-Godínez,et al.  Immunolocalization of Sphingolipid Catabolism Enzymes along the Nephron: Novel Early Urinary Biomarkers of Renal Damage , 2023, International journal of molecular sciences.

[81]  V. Pesce,et al.  Different Effects of High-Fat/High-Sucrose and High-Fructose Diets on Advanced Glycation End-Product Accumulation and on Mitochondrial Involvement in Heart and Skeletal Muscle in Mice , 2023, Nutrients.

[82]  R. Virmani,et al.  Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies , 2023, Arteriosclerosis, thrombosis, and vascular biology.

[83]  B. Nordestgaard,et al.  Remnant cholesterol and low-grade inflammation jointly in atherosclerotic cardiovascular disease: implications for clinical trials , 2023, Current opinion in clinical nutrition and metabolic care.

[84]  C. P. Dos Santos,et al.  Parental fructose consumption induces early baroreflex dysfunction in offspring: impact on arterial pressure and on insulin resistance , 2023, International journal of obesity.

[85]  X. Puéchal,et al.  Dysregulation of neutrophil oxidant production and interleukin-1-related cytokines in granulomatosis with polyangiitis. , 2023, Rheumatology.

[86]  Lele Feng,et al.  Epicardial adipose tissue, metabolic disorders, and cardiovascular diseases: recent advances classified by research methodologies , 2023, MedComm.

[87]  A. Banerjee,et al.  Fatty Acids and their Proteins in Adipose Tissue Inflammation , 2023, Cell biochemistry and biophysics.

[88]  Zheng‐Da Pang,et al.  Nogo-B mediates endothelial oxidative stress and inflammation to promote coronary atherosclerosis in pressure-overloaded mouse hearts , 2023, Redox biology.

[89]  Gowri Palanissami,et al.  AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers , 2023, Exploration of targeted anti-tumor therapy.

[90]  K. Gutbrod,et al.  Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus , 2023, BMC Cardiovascular Disorders.

[91]  B. Wasita,et al.  Effect of Dapagliflozin on Patients with Rheumatic Heart Disease Mitral Stenosis , 2023, Journal of clinical medicine.

[92]  Anindita Das,et al.  mTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging , 2023, International journal of molecular sciences.

[93]  M. U. Khan,et al.  Natural Allies for Heart Health: Nrf2 Activation and Cardiovascular Disease Management. , 2023, Current problems in cardiology.

[94]  Shi-you Chen,et al.  Vagus nerve stimulation‐induced stromal cell‐derived factor‐l alpha participates in angiogenesis and repair of infarcted hearts , 2023, ESC heart failure.

[95]  K. Kuča,et al.  Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging , 2023, Archives of Toxicology.

[96]  P. Libby,et al.  Inflammation in acute myocardial infarction: the good, the bad and the ugly , 2023, European heart journal.

[97]  Fuquan Wang,et al.  Toll-like receptor 4: A potential therapeutic target for multiple human diseases. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[98]  Lawrence A Leiter,et al.  Fructose-containing food sources and blood pressure: A systematic review and meta-analysis of controlled feeding trials , 2023, PloS one.

[99]  P. Mailloux-Salinas,et al.  Combined fructose and sucrose consumption from an early age aggravates cardiac oxidative damage and causes a dilated cardiomyopathy in SHR rats , 2023, Journal of clinical biochemistry and nutrition.

[100]  Suo Xu,et al.  Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics , 2023, Acta Pharmacologica Sinica.

[101]  Yinghan Shi,et al.  VNN1 as a potential biomarker for sepsis diagnosis and its implications in immune infiltration and tumor prognosis , 2023, Frontiers in medicine.

[102]  Li-ting Zhou,et al.  The effects of brominated flame retardants (BFRs) on pro-atherosclerosis mechanisms. , 2023, Ecotoxicology and environmental safety.

[103]  S. Bhadada,et al.  AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: A narrative review. , 2023, Bone.

[104]  S. Sideris,et al.  Angiotensin Regulation of Vascular Homeostasis: Exploring the Role of ROS and RAS Blockers , 2023, International journal of molecular sciences.

[105]  A. Paziewska,et al.  The Ketogenic Diet and Cardiovascular Diseases , 2023, Nutrients.

[106]  F. Stentz,et al.  Ceramides and other sphingolipids as predictors of incident dysglycemia (CASPID): Design, methods, and baseline characteristics , 2023, Experimental biology and medicine.

[107]  Shu Li,et al.  Bisphenol A Regulates the TNFR1 Pathway and Excessive ROS Mediated by miR-26a-5p/ADAM17 Axis to Aggravate Selenium Deficiency-Induced Necroptosis in Broiler Veins , 2023, Biological trace element research.

[108]  K. Czajkowski,et al.  Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism , 2023, International journal of molecular sciences.

[109]  Tian Tian,et al.  mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy , 2023, International journal of molecular sciences.

[110]  S. Sharma,et al.  Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis , 2023, Naunyn-Schmiedeberg's archives of pharmacology.

[111]  H. Tomiyama Vascular function: a key player in hypertension , 2023, Hypertension Research.

[112]  O. Zimba,et al.  Cardiovascular issues in rheumatic diseases , 2023, Clinical Rheumatology.

[113]  R. de Caterina,et al.  NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis. , 2023, Cardiovascular research.

[114]  H. Tilg,et al.  An international multidisciplinary consensus statement on MAFLD and the risk of CVD , 2023, Hepatology International.

[115]  H. Riezman,et al.  Lipid metabolism around the body clocks. , 2023, Progress in lipid research.

[116]  A. Severino,et al.  Meta-Inflammation and New Anti-Diabetic Drugs: A New Chance to Knock Down Residual Cardiovascular Risk , 2023, International journal of molecular sciences.

[117]  D. Tousoulis,et al.  Epicardial adipose tissue in myocardial disease: from physiology to heart failure phenotypes. , 2023, Current problems in cardiology.

[118]  Wenyi Wei,et al.  Inactivation of Minar2 in mice hyperactivates mTOR signaling and results in obesity , 2023, Molecular metabolism.

[119]  Muxing Kang,et al.  VNN1 overexpression in pancreatic cancer cells inhibits paraneoplastic islet function by increasing oxidative stress and inducing β‑cell dedifferentiation , 2023, Oncology reports.

[120]  Annet Kirabo,et al.  Mechanisms of Oxidative Stress in Metabolic Syndrome , 2023, International journal of molecular sciences.

[121]  M. Madhur,et al.  Inflammation Resolution in the Cardiovascular System: Arterial Hypertension, Atherosclerosis, and Ischemic Heart Disease. , 2023, Antioxidants & redox signaling.

[122]  Jingfang Liu,et al.  Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy , 2023, Frontiers in Endocrinology.

[123]  Y. Chen,et al.  Growth differentiation factor-15/adiponectin ratio as a potential biomarker for metabolic syndrome in Han Chinese , 2023, Frontiers in Endocrinology.

[124]  P. Calder,et al.  Anthocyanins ameliorate obesity-associated metainflammation: Preclinical and clinical evidence. , 2023, Nutrition research.

[125]  G. Aroca-Martínez,et al.  Novel Biomarkers of Diabetic Kidney Disease , 2023, Biomolecules.

[126]  M. Mayr,et al.  Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction , 2023, European heart journal.

[127]  D. Agrawal,et al.  Role of sirtuins in attenuating plaque vulnerability in atherosclerosis , 2023, Molecular and cellular biochemistry.

[128]  Fan Zhang,et al.  Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[129]  A. Belfiore,et al.  Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy , 2023, Endocrine reviews.

[130]  Zhongzhou Guo,et al.  Proline/serine‐rich coiled‐coil protein 1 inhibits macrophage inflammation and delays atherosclerotic progression by binding to Annexin A2 , 2023, Clinical and translational medicine.

[131]  Jianping Ma,et al.  Total sugar, added sugar, fructose, and sucrose intake and all-cause, cardiovascular, and cancer mortality: A systematic review and dose-response meta-analysis of prospective cohort studies. , 2023, Nutrition.

[132]  J. Frampton Inclisiran: A Review in Hypercholesterolemia , 2023, American Journal of Cardiovascular Drugs.

[133]  J. Goldberger,et al.  Human Epicardial Adipose Tissue Expresses Glucose-dependent Insulinotropic Polypeptide, Glucagon and Glucagon-Like Peptide 1 Receptors as Potential Targets of Pleiotropic Therapies. , 2023, European journal of preventive cardiology.

[134]  D. Atar,et al.  Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE , 2023, Circulation.

[135]  Stephen J. Nicholls PCSK9 inhibitors and reduction in cardiovascular events: Current evidence and future perspectives. , 2023, Kardiologia polska.

[136]  C. Kendall,et al.  The Effect of Non-Nutritive Sweetened Beverages on Postprandial Glycemic and Endocrine Responses: A Systematic Review and Network Meta-Analysis , 2023, Nutrients.

[137]  L. Rallidis,et al.  Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease. , 2023, International journal of cardiology.

[138]  D. Tousoulis,et al.  Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment , 2023, Molecules.

[139]  N. Mehta,et al.  Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis , 2023, Frontiers in Cardiovascular Medicine.

[140]  Zenglei Zhang,et al.  Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets , 2023, Frontiers in Immunology.

[141]  M. Ciccarelli,et al.  The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers , 2023, Biomolecules.

[142]  Xueyuan Yang,et al.  Epicardial Adipose Tissue and Diabetic Cardiomyopathy , 2023, Journal of cardiovascular pharmacology and therapeutics.

[143]  P. Duell Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease Risk. , 2023, Journal of the American College of Cardiology.

[144]  Hun‐Sung Kim,et al.  Long-Term Risk of Cardiovascular Disease Among Type 2 Diabetes Patients According to Average and Visit-to-Visit Variations of HbA1c Levels During the First 3 Years of Diabetes Diagnosis , 2022, Journal of Korean medical science.

[145]  Ewa Rusak,et al.  Atherosclerosis: risk assessment and the role of aiming for optimal glycaemic control in young patients with type 1 diabetes , 2022, Pediatric endocrinology, diabetes, and metabolism.

[146]  F. Crea,et al.  GLUT-1/PKM2 loop dysregulation in patients with non-ST-segment elevation myocardial infarction promotes metainflammation. , 2022, Cardiovascular research.

[147]  Guibo Sun,et al.  Role of Adiponectin in Cardiovascular Diseases Related to Glucose and Lipid Metabolism Disorders , 2022, International journal of molecular sciences.

[148]  Yabing Zhang,et al.  The Relationship Between Major Food Sources of Fructose and Cardiovascular Outcomes: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies , 2022, Advances in nutrition.

[149]  S. Chatterjee,et al.  Glycosphingolipids in Diabetes, Oxidative Stress, and Cardiovascular Disease: Prevention in Experimental Animal Models , 2022, International journal of molecular sciences.

[150]  Beata Franczyk,et al.  The Role of Inflammation and Oxidative Stress in Rheumatic Heart Disease , 2022, International journal of molecular sciences.

[151]  J Zhang,et al.  Associations among carotid plaque progression, cerebrovascular/cardiovascular diseases and LDL-C/non-HDL-C goal achievement in diabetic patients: A retrospective cohort study. , 2022, Journal of diabetes and its complications.

[152]  M. Sevick,et al.  The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease. , 2022, Cardiovascular research.

[153]  M. Bennett,et al.  The Role of Oxidative Stress in Atherosclerosis , 2022, Cells.

[154]  D. Gómez-Coronado,et al.  Macrophage-Derived 25-Hydroxycholesterol Promotes Vascular Inflammation, Atherogenesis, and Lesion Remodeling , 2022, Circulation.

[155]  S. Pan,et al.  Cardiovascular Manifestations in Rheumatoid Arthritis , 2022, Cardiology in review.

[156]  Beiyan Zhou,et al.  Macrophages at the Crossroad of Meta-Inflammation and Inflammaging , 2022, Genes.

[157]  R. Laaksonen,et al.  Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly. , 2022, Clinical chemistry.

[158]  Faheem,et al.  Fathoming the role of mTOR in diabetes mellitus and its complications. , 2022, Current molecular pharmacology.

[159]  Qi Chen,et al.  Angiotensin-converting enzyme 2 improves hepatic insulin resistance by regulating GABAergic signaling in the liver , 2022, The Journal of biological chemistry.

[160]  Yanqiao Zhang,et al.  Activating transcription factor 3, glucolipid metabolism, and metabolic diseases , 2022, Journal of molecular cell biology.

[161]  Lawrence A Leiter,et al.  Effect of Important Food Sources of Fructose-Containing Sugars on Inflammatory Biomarkers: A Systematic Review and Meta-Analysis of Controlled Feeding Trials , 2022, Nutrients.

[162]  Peifeng Li,et al.  The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes , 2022, Frontiers in Physiology.

[163]  Lang Li,et al.  Inflammation and Oxidative Stress Role of S100A12 as a Potential Diagnostic and Therapeutic Biomarker in Acute Myocardial Infarction , 2022, Oxidative medicine and cellular longevity.

[164]  M. Shariq,et al.  Aftermath of AGE-RAGE Cascade in the pathophysiology of cardiovascular ailments. , 2022, Life sciences.

[165]  A. Hingorani,et al.  Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study. , 2022, JAMA cardiology.

[166]  R. Goulart,et al.  The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review , 2022, International journal of molecular sciences.

[167]  P. Whitfield,et al.  Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR−/− mice , 2022, bioRxiv.

[168]  A. Donato,et al.  Mechanisms and consequences of endothelial cell senescence , 2022, Nature Reviews Cardiology.

[169]  M. Takeuchi,et al.  Effects of Toxic AGEs (TAGE) on Human Health , 2022, Cells.

[170]  A. Franco-Obregón,et al.  Magnetic field therapy enhances muscle mitochondrial bioenergetics and attenuates systemic ceramide levels following ACL reconstruction: Southeast Asian randomized-controlled pilot trial , 2022, Journal of orthopaedic translation.

[171]  Lawrence A Leiter,et al.  Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials , 2022, Nutrients.

[172]  A. Flouris,et al.  The impact of adipokines on vascular networks in adipose tissue. , 2022, Cytokine & growth factor reviews.

[173]  B. Lakkakula,et al.  Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases , 2022, Oxidative medicine and cellular longevity.

[174]  Chang Liu,et al.  Investigation of Statin Medication Use in Elderly Patients with Cardiovascular Disease on Regular Physical Examination and the Relationship with Glucolipid Metabolism and Adverse Cardiovascular Prognosis , 2022, Disease markers.

[175]  Xingmin Li,et al.  Alteration of Mitochondrial Lipidome and Its Potential Effect on Apoptosis, Mitochondrial Reactive Oxygen Species Production, and Muscle Oxidation in Beef during Early Postmortem. , 2022, Journal of agricultural and food chemistry.

[176]  Lun Xiao,et al.  The Determinants of Adolescent Glycolipid Metabolism Disorder: A Cohort Study , 2022, International journal of endocrinology.

[177]  G. Czarnota,et al.  Involvement of Ceramide Signalling in Radiation-Induced Tumour Vascular Effects and Vascular-Targeted Therapy , 2022, International journal of molecular sciences.

[178]  M. Kals,et al.  Markers of Inflammation, Oxidative Stress, and Fibrosis in Patients with Atrial Fibrillation , 2022, Oxidative medicine and cellular longevity.

[179]  Yuchen Tang,et al.  A Meta-Analysis of High-Intensity Interval Training on Glycolipid Metabolism in Children With Metabolic Disorders , 2022, Frontiers in Pediatrics.

[180]  B. Crespo-Facorro,et al.  Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort. , 2022, Spanish journal of psychiatry and mental health.

[181]  Ł. Bułdak Cardiovascular Diseases—A Focus on Atherosclerosis, Its Prophylaxis, Complications and Recent Advancements in Therapies , 2022, International journal of molecular sciences.

[182]  A. Twarda-Clapa,et al.  Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs , 2022, Cells.

[183]  A. Adem,et al.  Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives , 2022, Biomolecules.

[184]  P. Holvoet,et al.  Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs , 2022, The Yale journal of biology and medicine.

[185]  Shi Qi Li,et al.  Changes of circulating biomarkers of inflammation and glycolipid metabolism by CPAP in OSA patients: a meta-analysis of time-dependent profiles , 2022, Therapeutic advances in chronic disease.

[186]  U. P. Flato,et al.  Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future , 2022, International journal of molecular sciences.

[187]  Daniel de Bortoli Teixeira,et al.  GLP-1a: Going beyond Traditional Use , 2022, International journal of molecular sciences.

[188]  X. Xia,et al.  GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[189]  Hai-Jian Sun,et al.  A narrative review of plant and herbal medicines for delaying diabetic atherosclerosis: an update and future perspectives. , 2021, Reviews in cardiovascular medicine.

[190]  K. Krüger,et al.  Type and Intensity as Key Variable of Exercise in Metainflammation diseases: A Review , 2021, International Journal of Sports Medicine.

[191]  R. Sah,et al.  Links between ceramides and cardiac function , 2021, Current opinion in lipidology.

[192]  A. Jayedi,et al.  The relationship between major food sources of fructose and cardiovascular disease, cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of cohort studies , 2021, Critical reviews in food science and nutrition.

[193]  S. Emamgholipour,et al.  Polyphenols: Potential anti‐inflammatory agents for treatment of metabolic disorders , 2021, Phytotherapy research : PTR.

[194]  M. Kwiatkowski,et al.  Meta-Inflammation and Metabolic Reprogramming of Macrophages in Diabetes and Obesity: The Importance of Metabolites , 2021, Frontiers in Immunology.

[195]  J. Bissler,et al.  Leptin receptor defect with diabetes causes skeletal muscle atrophy in female obese Zucker rats where peculiar depots networked with mitochondrial damages , 2021, Ultrastructural pathology.

[196]  M. Bechara,et al.  Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors , 2021, Diabetes/metabolism research and reviews.

[197]  A. Girotti,et al.  Pathophysiological potential of lipid hydroperoxide intermembrane translocation: Cholesterol hydroperoxide translocation as a special case , 2021, Redox biology.

[198]  F. Rodríguez‐Artalejo,et al.  Metabolic syndrome and Growth Differentiation Factor 15 in older adults , 2021, GeroScience.

[199]  Xin Liu,et al.  Distinct metabonomic signatures of Polygoni Multiflori Radix Praeparata against glucolipid metabolic disorders. , 2021, The Journal of pharmacy and pharmacology.

[200]  Ariel D. Quiroga,et al.  Mitochondria-rough-ER contacts in the liver regulate systemic lipid homeostasis. , 2021, Cell reports.

[201]  Joseph A. Hill,et al.  Cardiometabolic disease: Mechanisms to therapies. , 2021, Journal of molecular and cellular cardiology.

[202]  U. P. Flato,et al.  Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions , 2021, International journal of molecular sciences.

[203]  K. Prasad AGE–RAGE Stress and Coronary Artery Disease , 2021, International Journal of Angiology.

[204]  Yanduan Lin,et al.  Hypothalamus-pituitary-adrenal Axis in Glucolipid metabolic disorders , 2020, Reviews in Endocrine and Metabolic Disorders.

[205]  N. Esmaeil,et al.  Meta-inflammatory state and insulin resistance can improve after 10 weeks of combined all-extremity high-intensity interval training in sedentary overweight/obese females: a quasi-experimental study , 2020, Journal of Diabetes & Metabolic Disorders.

[206]  Joseph A. Hill,et al.  Metabolic Inflammation in Heart Failure with Preserved Ejection Fraction. , 2020, Cardiovascular research.

[207]  A. Goldberg,et al.  Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes , 2020, Journal of Lipid Research.

[208]  F. Parveen,et al.  Role of Ceramidases in Sphingolipid Metabolism and Human Diseases , 2019, Cells.

[209]  J. H. Kim,et al.  High-Sensitivity C-Reactive Protein Is Associated with Prediabetes and Adiposity in Korean Youth. , 2019, Metabolic syndrome and related disorders.

[210]  L. Obeid,et al.  Molecular mechanisms of regulation of sphingosine kinase 1. , 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[211]  P. Hopkins,et al.  Skeletal muscle ceramides and relationship with insulin sensitivity after 2 weeks of simulated sedentary behaviour and recovery in healthy older adults , 2018, The Journal of physiology.

[212]  A. Xu,et al.  Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease , 2017, Chinese Journal of Integrative Medicine.

[213]  Kim Ekroos,et al.  Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol , 2016, European heart journal.

[214]  R. J. Tofano,et al.  Metabolic syndrome, atherosclerosis and inflammation: an inseparable triad? , 2015 .

[215]  R. DeFronzo,et al.  Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance , 2009, Diabetes.

[216]  T. S. Ramasamy,et al.  RNA therapeutics for treatment of diabetes. , 2024, Progress in molecular biology and translational science.

[217]  T. Toyomura,et al.  [Regulation of inflammatory response based on interaction among AGEs, DAMPs, and/or cytokines]. , 2022, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.